ARTBIO

Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize their potential.

Latest funding

$132M Series B+ · July 29, 2025

Led by B Capital · Source: fundraisingfox.com

Total raised: $245M across 3 sourced rounds

All 3 rounds ↓

Website: artbio.com.

X: @artbio_inc · 54 followers.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Health Care, Hospital, Medical, Medical Device.

Stage: Series B+.

Based in: Cambridge, United States.

Founded: 2021.

Total raised: $245M in 3 sourced rounds.

Last round: Jul 29, 2025 · 471 days ago.

Headcount: 51–100 employees.

On Recent Funding since: Nov 8, 2026.

Signals

X account@artbio_inc · created Jun 8, 2023 (3 years old) · 54 followers

Website registeredFeb 15, 2000 (26 years old)

TIMELINE · MONEY RAISED

ARTBIO | 50 days from X account to first raise on record

@artbio_inc·Raised $245M in 3 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

July 29, 2025
Series B+ · $132M
BB Capital (lead), SSofinnova Partners (lead), AAlexandria Venture Investments, FF-Prime Capital, OOmega Funds, QQatar Investment Authority, TThird Rock Ventures
Source: fundraisingfox.com
December 7, 2023
Series A · $90M
TThird Rock Ventures (lead), FF-Prime Capital, OOmega Funds
Source: fundraisingfox.com
July 28, 2023
Seed · $23M
FF-Prime Capital (lead), OOmega Funds
Source: bioworld.com
June 8, 2023
X account created
February 15, 2000
Website created

Founders and team

EO
Emanuele Ostuni Founder

@emanuele_ostuni · LinkedIn
ØS
Øyvind Sverre Bruland Founder
RH
Roy H. Larsen Founder
JF
Jonathan Freeman Chief Business Officer
NP
Nick Pullen Chief Scientific Officer

Investors

Companies like ARTBIO

AArtios Pharma$115M Series B+ · Nov 2025
MMariana Oncology$175M Series B+ · Sep 2023
AAdvanCell$315M Series B+ · Jul 2026
AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
TT-CURX$20M Series A · Dec 2025
MMyosin Therapeutics$3M Seed · Mar 2025

Other companies backed by B Capital

PProject Omega$80M Series A · Nov 2026
LLabelbox$100M Series B+ · Oct 2026
SSonilo$11M Seed · Oct 2026
PPaleBlueDot AI$200M Series B+ · Oct 2026
TTiny Health$33M Series B+ · Sep 2026
PPrecision Neuroscience$250M Series B+ · Sep 2026

B Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/artbio (get a free API key).